

The Hepatitis B Core Antibody (anti-HBc) is a type of antibody produced by the immune system in response to infection with the hepatitis B virus (HBV). These antibodies specifically target the core antigen of the virus, which is a protein found inside the viral particle.
The Hepatitis B (Core) Total Antibody detects the presence of hepatitis B core antibodies (anti-HBc) in the blood, which are present in the blood after exposure to the virus. It is useful for determining whether an individual has ever been infected with HBV, whether the infection is active, or if the individual has cleared the virus from their system. This test is valuable for evaluating individuals with a history of liver disease as well as those at risk of HBV infection, such as healthcare workers or individuals with multiple sexual partners. Detecting the presence of anti-HBc antibodies helps doctors differentiate between different phases of HBV infection and guide treatment decisions. Early diagnosis and intervention can help prevent complications such as cirrhosis or liver cancer, which are associated with chronic HBV infection.
A positive result generally indicates that the individual has had an exposure to hepatitis B at some point in their life, but it does not indicate whether the infection is currently active or resolved. To further clarify the current status of the infection, additional tests like the Hepatitis B surface antigen (HBsAg) or Hepatitis B DNA (viral load) tests can be recommended.
No special preparation is needed for this test. Eating and drinking can be done as per the daily routine. However, inform the doctor about all the medications or supplements or underlying liver disease, as these factors may influence the test results.
Lab test results may vary across laboratories. Abnormal test results require an expert interpretation. Do not self-medicate. Always consult a doctor to understand the test results correctly.
The Hepatitis B (Core) Total Antibody test identifies total antibodies (IgM and IgG) against the hepatitis B core antigen (anti-HBc). It is a key marker for determining whether an individual has ever been infected with the virus, regardless of whether the infection is currently active. By detecting the presence of anti-HBc, doctors can assess the progression of the infection and make informed decisions about treatment and monitoring. This test is crucial for understanding the history of hepatitis B in an individual, which can help prevent future liver damage and transmission of the virus.
The Hepatitis B (Core) Total Antibody test is done:
- To detect past exposure to the hepatitis B virus, identify individuals who may have resolved the infection or are at risk for chronic infection.
- To evaluate suspected or confirmed hepatitis B infection cases, especially acute or chronic.
- To assess the risk of infection transmission in individuals with chronic HBV infection or those who have recovered from a previous infection.
- To monitor individuals who have been treated for hepatitis B, helping to evaluate the effectiveness of antiviral therapy.
- No special preparation is required.























